Boston's world-class research universities, biotech corridor, and growing tech scene make it a premier H-1B destination. Learn which employers sponsor, what salaries look like, and how to break into this competitive market.
Boston's H-1B ecosystem is unlike any other U.S. metro. While Silicon Valley and Seattle are dominated by consumer and enterprise tech, Boston uniquely blends world-class academic medical centers, life sciences giants, and a fast-growing technology sector. Greater Boston — including Cambridge, Waltham, and the Route 128 corridor — hosts one of the densest concentrations of H-1B petitions in the Eastern U.S.
The city's anchor institutions — Harvard University, MIT, Massachusetts General Hospital, and Dana-Farber Cancer Institute — are among the largest cap-exempt H-1B employers in the country. Cap-exempt status means these institutions can file H-1B petitions at any time of year without competing in the annual April lottery, making Boston particularly attractive for foreign-born researchers and physicians.
Massachusetts Biotech corridor along Kendall Square in Cambridge has become one of the hottest life sciences markets in the world. Companies like Moderna, Biogen, Takeda, and Vertex Pharmaceuticals have headquartered or established major operations here, driving demand for computational biologists, clinical research associates, and pharmaceutical scientists on H-1B status.
The tech sector around Boston — anchored by companies like HubSpot, Wayfair, DraftKings, and a growing number of fintech and AI startups — has also matured significantly. This diversification means that H-1B candidates in software engineering, data science, and product management have strong alternatives to the pure-biotech path.
On the cap-exempt side, Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, MIT, and Boston University collectively file thousands of H-1B petitions each year for physicians, researchers, postdoctoral fellows, and faculty. These positions often lead to EB-1B or EB-2 NIW green card sponsorship given the academic nature of the work.
In biotech and pharma, Biogen, Moderna, Vertex Pharmaceuticals, Takeda, Shire, and Sanofi Genzyme are among Boston's largest H-1B sponsors. These companies hire computational chemists, clinical trial managers, bioinformaticians, and regulatory affairs specialists in significant numbers. The Kendall Square area has been dubbed 'the most innovative square mile on the planet' by MIT.
Tech companies with major Boston presences include Amazon (AWS office), Google Cambridge, Apple, Microsoft New England, HubSpot, Wayfair, and DraftKings. These employers offer H-1B sponsorship primarily for software engineers, data scientists, and machine learning researchers. Boston's Seaport District has become a hub for financial technology companies like State Street and Fidelity Investments, both significant H-1B filers.
The IT consulting and outsourcing sector is also heavily represented in Greater Boston. Cognizant, Infosys, Tata Consultancy Services, and Wipro maintain delivery centers in the region and frequently sponsor H-1B workers placed at local financial and healthcare clients. These paths can serve as stepping stones for international workers who do not receive direct sponsorship from end employers.
Boston's prevailing wages reflect a high-cost metropolitan economy. Software engineers at DOL Level II earn prevailing wages around $115,000 in the Boston-Cambridge-Newton MSA, while Level III (experienced) software developers command $140,000 to $160,000. Biotech roles vary significantly by specialty: bioinformatics scientists typically earn $100,000 to $130,000, while clinical research directors can command $160,000 to $200,000.
Massachusetts has a flat state income tax rate of 5%, relatively low compared to California's top marginal rate of 13.3%. This makes the after-tax difference less stark than the Bay Area comparison, though housing costs in Cambridge and Boston's Back Bay are among the highest on the East Coast.
Academic and research H-1B positions — particularly postdoctoral roles at MIT or Harvard — typically offer lower salaries ($55,000-$75,000) than industry positions. However, the prestige, networking access, and green card pathway advantages of these roles make them attractive despite the compensation gap for many international researchers.
Boston's biotech companies increasingly compete with tech giants for data science talent, pushing salaries for computational roles higher. Moderna's mRNA platform team and Biogen's digital health division offer compensation packages that rival those at established tech companies, including base salaries above $150,000 for experienced machine learning engineers.
For academic and hospital employers, Boston's cap-exempt H-1B market offers significant advantages. Institutions affiliated with universities or non-profit research organizations can file H-1B petitions at any time under Section 214(i)(1) of the INA, bypassing the April lottery entirely. This makes the H-1B pathway faster and more reliable for researchers, faculty, and physicians.
For cap-subject employers — biotech companies, tech firms, consulting firms — the standard April lottery process applies. Given Boston's proximity to top universities like Northeastern, Boston University, and Harvard, OPT-to-H-1B conversions are extremely common. Many Boston biotech and tech employers maintain active OPT pipeline programs specifically to capture this talent before the lottery.
Massachusetts has strong worker-protection laws that complement H-1B prevailing wage requirements. Employers must maintain Public Access Files and cannot underpay H-1B workers; the state Attorney General's office has historically been active in investigating wage theft in the tech and healthcare sectors.
Premium Processing, which reduces the USCIS adjudication timeline to 15 business days for an additional fee, is widely used by Boston employers for urgent H-1B transfers and extensions. If you are in a cap-subject situation and your start date is time-sensitive, confirm with your employer whether they will elect Premium Processing — most established Boston tech and biotech companies do.
Boston's job market is strongly network-driven, particularly in biotech where informal relationships between principal investigators, hiring managers, and candidates from shared graduate programs often determine who gets interviewed. LinkedIn is essential, but so is attending local events: Kendall Square Association meetups, MassBio events, and conferences like ASHP or BIO International are where Boston's biotech hiring conversations happen.
For tech roles, BuiltIn Boston is the best local job board for companies that actively sponsor visas. The Boston tech community is active on Slack groups like Boston.tech.social and organizations like Mass Technology Leadership Council. Many companies post positions exclusively to their own sites before aggregating to Indeed or LinkedIn, so following target companies directly yields early access.
Academic researchers should prioritize publications and presentation opportunities at conferences. A strong CV with first-author publications in high-impact journals dramatically improves your H-1B petition quality for university and hospital employers, who require evidence of distinguished achievement for EB-1B petitions that often follow H-1B status.
Timing is critical for OPT-to-H-1B conversions in Boston. Given the STEM OPT extension allows 3 years of work authorization for qualified graduates, plan to start your H-1B process while on STEM OPT. Register for the lottery in March, and if selected, file in April for an October 1 start — giving you overlap time if you are still on OPT.
Our team analyzes USCIS disclosure data, DOL wage records, and employer H-1B filings to produce accurate, actionable guides for international job seekers navigating the U.S. work visa process.